CME 
JOBS 
OUTBREAKS 
PEER-TO-PEER 
QUIZZES & QUESTIONS 
MEDTECH Roswell Park Comprehensive Cancer Center Shines at ASCO 2023
Roswell Park Comprehensive Cancer Center recently showcased a series of groundbreaking research studies at the American Society of Clinical Research (ASCO) 2023 meeting, highlighting their commitment to advancing cancer management and clinical trials.
- Roswell Park presented a variety of studies at ASCO 2023, including research on colorectal cancer, breast cancer, and the impact of physical activity on multiple myeloma patients.
- Dr. Deepak Vadehra and Sarbajit Mukherjee presented a study on transcriptional metabolic profiling in young onset colorectal cancer patients.
- Jasmin Gill and Dr. Anurag Singh presented research on racial/ethnic differences in 21-gene recurrence score and survival among estrogen receptor-positive breast cancer patients.
- Janine Joseph and Dr. Jens Hillengass presented a poster abstract on the impact of physical activity intervention on T cell exhaustion in multiple myeloma patients.
- Dr. Igor Puzanov chaired an education session on the evolving management of Stage IV Melanoma.
- Dr. Kara Kelly represented Children’s Oncology Group on a study of nivolumab versus brentuximab vedotin in advanced stage classic Hodgkin lymphoma.
- Five additional Roswell Park teams presented Trials in Progress Submission (TPS) abstracts, highlighting ongoing studies in various areas of oncology.
“This study has revealed differences in transcriptional metabolic profiles and other drivers of disease, as well as immune profiles, between younger and older CRC populations. This biology should be explored in the future, as new avenues for treatment in younger CRC populations.”
Dr. Deepak Vadehra from the “Transcriptional metabolic profiling in young onset colorectal cancer (CRC) patients” study
